In the press

Andes study: the possibility of treating HIV with only one pill

Richmond Labs, in coordination with Huesped Foundation, launched an innovative project that aims to analyze and study the efficacy and security of the mixture of two different drugs.
READ MORE

Launch of new medicine for HIV

Laboratorios Richmond launches to the pharmaceutical market VIRONTAR N, the first Fixed-Dose Combination of Darunavir 800 mg and Ritonavir 100 mg in Argentina.
READ MORE

Issue of negotiable bonds

Laboratorios Richmond successfully placed negotiable bonds for $ 20 million, at an interest rate similar to that obtained by leading companies of the country. Among the main destinations of the subscribed capital it is to increase the productive capacity of the plant in Pilar.
READ MORE

Distinction in good environmental practices

Tuesday July 7th, Laboratorios Richmond received the "Certificate of Recognition of Good Environmental Practices in Industry" from the municipality of Pilar.
READ MORE

Celebration of 80th anniversary

Richmond celebrated the eighty years since its founding with a cocktail at the Yacht Club Puerto Madero, which was attended bynational authorities, businessmen, politicians and referents for science and research.
READ MORE

Laboratorios Richmond obtains Invima certification

INVIMA has settled that Laboratorios Richmond´s plant located in Pilar complies with the good manufacturing practices for pharmaceutical manufacturing and secondary packaging of medicines.
READ MORE

First fixed dose combination for HIV treatment

Richmond launches "Virontar", a compound that summarizes in one tablet two antiretrovirals, Darunavir and Ritonavir, which prevent the multiplication of the HIV virus and reduce its concentration in the blood. This fixed dose combination can lower the amount of ingested tablets in half, which facilitates vital treatment adherence and limits the risk of viral resistance.
READ MORE

Vision of the Leaders 2013

In the special edition of El Cronista on "Vision of Leaders 2013”, Marcelo Figueiras, President of Laboratorios Richmond answered the questionnaire about the faced obstacles and the balance sheet for the year ending and expectations and projects of the company and the public policies necessary for the sector for 2013.
READ MORE